gliclazide

Gliclazide is an oral antihyperglycemicagent which is used for the treatment of non-insulin-dependent diabetes mellitus. It is considered a first-generation sulfonylurea due to the structural presence of a sulfonamide group able to release a proton and the presence of one aromatic group. Reference standards of Gliclazide API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => gliclazide impurity F (366RB)
    [catalogue_number] => PA BP366RB
    [category_ids] => ,153,
    [chemical_name] => 
    [weight] => NA
    [form] => NA
    [cas] => NA
    [pslug] => gliclazide-impurity-f-366rb-pabp366rb
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)

gliclazide impurity F (366RB)

Catalogue No.:PA BP366RB
CAS :
NA
Molecular Formula : NA
Molecular Weight : NA

Enquire

Details

stdClass Object
(
    [pname] => gliclazide (368RB)
    [catalogue_number] => PA BP368RB
    [category_ids] => ,153,
    [chemical_name] => 
    [weight] => NA
    [form] => NA
    [cas] => NA
    [pslug] => gliclazide-368rb-pabp368rb
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)